Federal Register Notice Regarding Policy for Labs Performing Coronavirus Tests
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled “Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency.”
Click here to see the full document.
